EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 63 filers reported holding EVELO BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20,607 | +11160.7% | 113,850 | 0.0% | 0.04% | -90.2% |
| Q4 2022 | $183 | -100.0% | 113,850 | 0.0% | 0.38% | -69.2% |
| Q3 2021 | $802,000 | -48.7% | 113,850 | 0.0% | 1.23% | -46.9% |
| Q2 2021 | $1,564,000 | +28.4% | 113,850 | 0.0% | 2.31% | +56.5% |
| Q1 2021 | $1,218,000 | -11.5% | 113,850 | 0.0% | 1.48% | -19.7% |
| Q4 2020 | $1,376,000 | – | 113,850 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 18,233,403 | $215,154,000 | 41.21% |
| HARBOURVEST PARTNERS LLC | 1,763,505 | $20,809,000 | 26.29% |
| Alphabet Inc. | 1,060,495 | $12,514,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 437,500 | $5,163,000 | 0.58% |
| DC Investments Management, LLC | 36,924 | $436,000 | 0.28% |
| ARK Investment Management | 126,831 | $1,497,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 22,998 | $271,000 | 0.03% |
| Laurion Capital Management LP | 150,000 | $1,770,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 9,380 | $111,000 | 0.01% |
| CREDIT SUISSE AG/ | 440,169 | $5,194,000 | 0.01% |